Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Tag
  • C-His-Avi
    (51)
  • C-6xHis
    (10)
  • N-His
    (5)
  • N-6xHis
    (3)
  • C-Myc
    (1)
  • N-10xHis
    (1)
  • N-6xHis-SUMO
    (1)
  • N-GST
    (1)
  • N-His-Avi
    (1)
TargetMol | Tags By Expression System
  • HEK293 Cells
    (39)
  • E. coli
    (29)
  • Baculovirus Insect Cells
    (5)
TargetMol | Tags By Species
  • Human
    (58)
  • BCoV
    (9)
  • E. coli
    (2)
  • HCoV-OC43
    (1)
  • Influenza B
    (1)
  • Salmonella enteritidis
    (1)
  • Serratia marcescens
    (1)
TargetMol | Tags By SPR-compatible Buffer
  • Ready-to-use
    (49)
  • Buffer exchange required
    (24)
Filter
Search Result
Results for "

ns 2

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    13
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    2
    TargetMol | Peptide_Products
  • Recombinant Protein
    73
    TargetMol | Recombinant_Protein
  • Isotope Products
    1
    TargetMol | Isotope_Products
TargetMolTargetMolCompare
Bovine coronavirus (strain 98TXSF-110-ENT) Non-structural Protein 2a (His)
ns2a, ns2, Non-structural protein 2a, 32 kDa non-structural protein, 32 kDa accessory protein
TMPH-00239
Expression system: Baculovirus Insect Cells
Length: 1-278, Full Length
Activity: Not Tested
  • Inquiry Price
20 days
Size
QTY
TargetMolTargetMolCompare
Bovine coronavirus (strain LSU-94LSS-051) Non-structural Protein 2a (Baculovirus, His)
ns2a, ns2, Non-structural protein 2a, 32 kDa non-structural protein, 32 kDa accessory protein
TMPH-00233
Expression system: Baculovirus Insect Cells
Length: 1-278, Full Length
Activity: Not Tested
  • Inquiry Price
20 days
Size
QTY
TargetMolTargetMolCompare
Bovine coronavirus (strain LY-138) Non-structural Protein 2a (Baculoviru, His)
ns2a, ns2, Non-structural protein 2a, 32 kDa non-structural protein, 32 kDa accessory protein
TMPH-00241
Expression system: Baculovirus Insect Cells
Length: 1-278, Full Length
Activity: Not Tested
  • Inquiry Price
20 days
Size
QTY
TargetMolTargetMolCompare
Bovine coronavirus (strain Mebus) Non-structural Protein 2a (Baculovirus, His)
ns2a, ns2, Non-structural protein 2a, 32 kDa non-structural protein, 32 kDa accessory protein
TMPH-00238
Expression system: Baculovirus Insect Cells
Length: 1-278, Full Length
Activity: Not Tested
  • Inquiry Price
20 days
Size
QTY
TargetMolTargetMolCompare
Human coronavirus OC43 Non-structural protein 2a (His)
ns2a, ns2, Non-structural protein 2a, 32 kDa non-structural protein, 32 kDa accessory protein
TMPH-01152
Expression system: Baculovirus Insect Cells
Length: 1-278, Full Length
Activity: Not Tested
  • Inquiry Price
20 days
Size
QTY
TargetMolTargetMolCompare
DNA-binding protein HU-alpha Protein, E. coli O157:H7, Recombinant (His & SUMO)
NS2, hupA, HU-2, DNA-binding protein HU-alpha
TMPH-00668
Expression system: E. coli
Length: 1-90, Full Length
Activity: Not Tested
  • Inquiry Price
20 days
Size
QTY
TargetMolTargetMolCompare
Bovine coronavirus (strain Quebec) Non-structural Protein 2a (His)
ns2a, ns2, Non-structural protein 2a, 32 kDa non-structural protein, 32 kDa accessory protein
TMPH-00236
Expression system: E. coli
Length: 1-277, Full Length
Activity: Not Tested
  • Inquiry Price
20 days
Size
QTY
TargetMolTargetMolCompare
Bovine coronavirus (strain 98TXSF-110-LUN) Non-structural Protein 2a (His)
ns2a, ns2, Non-structural protein 2a, 32 kDa non-structural protein, 32 kDa accessory protein
TMPH-00235
Expression system: HEK293 Cells
Length: 1-278, Full Length
Activity: Not Tested
  • Inquiry Price
20 days
Size
QTY
TargetMolTargetMolCompare
Influenza B (strain B/Yamagata/1/1973) Nuclear export Protein (His)
Nuclear export protein, NS, Non-structural protein 2 (NS2), NEP
TMPH-02359
Expression system: E. coli
Length: 1-122, Full Length
Activity: Not Tested
  • Inquiry Price
20 days
Size
QTY
TargetMolTargetMolCompare
KRAS Protein,Human,Recombinant(G12D & Q61H, His)
RASK2, RALD, NS3, NS, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-RAS, Kirsten rat sarcoma viral oncogene homolog, KI-RAS, C-K-RAS, CFC2
TMPY-04113
KRAS Protein,Human,Recombinant(G12D & Q61H, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 23.3 kDa and the accession number is P01116-2.
  • Inquiry Price
7-10 days
Size
QTY
TargetMol | Inhibitor Sale
SPR-compatible buffer
TargetMolTargetMolCompare
KRAS Protein,Human, Recombinant (Q61H, His)
RASK2, RALD, NS3, NS, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-RAS, Kirsten rat sarcoma viral oncogene homolog, KI-RAS, C-K-RAS, CFC2
TMPY-01888
KRAS Protein,Human, Recombinant (Q61H, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 22.5 kDa and the accession number is P01116-2.
  • Inquiry Price
7-10 days
Size
QTY
TargetMol | Inhibitor Sale
TargetMolTargetMolCompare
KRAS Protein,Human,Recombinant(G12C & Q61H, His)
RASK2, RALD, NS3, NS, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-RAS, Kirsten rat sarcoma viral oncogene homolog, KI-RAS, C-K-RAS, CFC2
TMPY-04116
KRAS Protein,Human,Recombinant(G12C & Q61H, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 23.3 kDa and the accession number is P01116-2.
  • Inquiry Price
7-10 days
Size
QTY
TargetMol | Inhibitor Sale
SPR-compatible buffer
TargetMolTargetMolCompare
HLA-A*03:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
RASK2, RALD, NS3, NS, MHC, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-Ras 2, KRAS, KI-RAS, GTPase Kras, C-K-RAS, CFC2
TMPK-01453
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
  • Inquiry Price
7-10 days
Size
QTY
SPR-compatible buffer
TargetMolTargetMolCompare
HLA-A*02:01&B2M&KRAS WT (KLVVVGAGGV) Monomer Protein, Human, MHC (His & Avi), Biotinylated
RASK2, RALD, NS3, NS, MHC, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-Ras 2, KRAS, KI-RAS, GTPase Kras, C-K-RAS, CFC2
TMPK-01407
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target.
  • Inquiry Price
7-10 days
Size
QTY
SPR-compatible buffer
TargetMolTargetMolCompare
HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Tetramer Protein, Human, MHC (His & Avi), PE-Labeled
RASK2, RALD, NS3, NS, MHC, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-Ras 2, KRAS, KI-RAS, GTPase Kras, C-K-RAS, CFC2
TMPK-01439
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
  • Inquiry Price
7-10 days
Size
QTY
TargetMolTargetMolCompare
HLA-A*11:01&B2M&KRAS G12S (VVVGASGVGK) Tetramer Protein, Human, MHC (His & Avi)
RASK2, RALD, NS3, NS, MHC, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-Ras 2, KRAS, KI-RAS, GTPase Kras, C-K-RAS, CFC2
TMPK-01431
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
  • Inquiry Price
7-10 days
Size
QTY
SPR-compatible buffer
TargetMolTargetMolCompare
HLA-A*03:01&B2M&KRAS G12V (VVVGAVGVGK) Tetramer Protein, Human, MHC (His & Avi)
RASK2, RALD, NS3, NS, MHC, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-Ras 2, KRAS, KI-RAS, GTPase Kras, C-K-RAS, CFC2
TMPK-01526
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
  • Inquiry Price
7-10 days
Size
QTY
SPR-compatible buffer
TargetMolTargetMolCompare
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi), FITC-Labeled
RASK2, RALD, NS3, NS, MHC, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-Ras 2, KRAS, KI-RAS, GTPase Kras, C-K-RAS, CFC2
TMPK-01471
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target.
  • Inquiry Price
7-10 days
Size
QTY
SPR-compatible buffer
TargetMolTargetMolCompare
HLA-A*11:01&B2M&KRAS G12R (VVVGARGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
RASK2, RALD, NS3, NS, MHC, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-Ras 2, KRAS, KI-RAS, GTPase Kras, C-K-RAS, CFC2
TMPK-01464
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
  • Inquiry Price
7-10 days
Size
QTY
SPR-compatible buffer
TargetMolTargetMolCompare
HLA-A*11:01&B2M&KRAS G12A (VVVGAAGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
RASK2, RALD, NS3, NS, MHC, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-Ras 2, KRAS, KI-RAS, GTPase Kras, C-K-RAS, CFC2
TMPK-01457
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
  • Inquiry Price
7-10 days
Size
QTY
SPR-compatible buffer
TargetMolTargetMolCompare
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Tetramer Protein, Human, MHC (His & Avi)
RASK2, RALD, NS3, NS, MHC, K-RAS4B, K-RAS4A, K-RAS2B, K-RAS2A, KRAS2, KRAS1, K-Ras 2, KRAS, KI-RAS, GTPase Kras, C-K-RAS, CFC2
TMPK-01489
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target.
  • Inquiry Price
7-10 days
Size
QTY
SPR-compatible buffer